Prostatic Marker-Negative Amphicrine Carcinoma of the Prostate

References

• Bentz MS, Cohen C, Budgeon LR, Demers TM. Evaluation of commercial immunoperoxidase kits in diagnosis of prostatic carcinoma. Urology 1984; 23: 75–78
   PubMed Web of Science ®Google Scholar
• Manley PN, Mahon DE, Bruce AW, Franchi RT. Prostate specific acid phosphatase. Diagnostic Immunohistochemistry, RA DeLellis. Masson, New York, NY 1981; 313–324
   Google Scholar
• Najdi M, Tabei SZ, Castro A, et al. Prostate specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer 1981; 48: 1229–1232
   PubMed Web of Science ®Google Scholar
• Bentz MS, Cohen C, Demers LM, Budgeon LR. Immunohistochemical demonstration of prostatic origin of metastases. Urology 1982; 19: 584–586
   PubMed Web of Science ®Google Scholar
• Bentz MS, Cohen C, Demers LM, Budgeon LR. Immunohistochemical acid phosphatase level and tumor grade in prostatic carcinoma. Arch Pathol Lab Med. 1982; 106: 476–480
   PubMed Web of Science ®Google Scholar
• Ellis DW, Leffers S, Davies JS, Ng ABP. Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate. Am J Clin Pathol. 1984; 81: 279–284
   PubMed Web of Science ®Google Scholar
• Ford TF, Butcher DN, Masters JRW, Parkinson MC. Immunocytochemical localization of prostate-specific antigen: specificity and application to clinical practice. Br J Urol. 1985; 57: 50–55
   PubMedGoogle Scholar
• Jobsis AC, de Vries GP, Meijer AEFM, Ploem JS. The immunohistochemical detection of prostatic acid phosphatase, its possibilities and limitations in tumor histochemistry. Histochem J. 1981; 13: 961–973
   PubMedGoogle Scholar
• Shevchuk MM, Romas NA, Ng PY, Tannenbaum M, Olsson CA. Acid phosphatase localization in prostatic carcinoma. A comparison of monoclonal antibody to heteroantisera. Cancer 1983; 52: 1642–1646
   PubMed Web of Science ®Google Scholar
• Bates RJ, Chapman CM, Prout GR, Liu CW. Immunohistochemical identification of prostatic acid phosphatase: correlation of tumor grade with acid phosphatase distribution. J Urol. 1982; 127: 574–580
   PubMed Web of Science ®Google Scholar
• Keshgegian AA, Kline TS. Immunoperoxidase demonstration of prostate acid phosphatase in aspiration biopsy cytology. Am J Clin Pathol. 1984; 82: 586–589
   PubMed Web of Science ®Google Scholar
• Svanholm H. Evaluation of commercial immunoperoxidase kits for prostatic-specific antigen and prostatic specific acid phosphatase. Acta Pathol Microbiol Immunol Scand A. 1986; 94: 7–12
   PubMedGoogle Scholar
• Abrahamson PA, Wadstrom LB, Alumets J, Falkmer S, Grimelius L. Peptide-hormones and serotonin-immunoreactive tumor cells in carcinoma of the prostate. Pathol Res Pract. 1987; 182: 298–307
   PubMed Web of Science ®Google Scholar
• Abrahamson PA, Falkmer S, Fait K, Grimelius L. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”. Pathol Res Pract. 1989; 185: 373–380
   PubMed Web of Science ®Google Scholar
• Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987; 59: 1803–1809
   PubMed Web of Science ®Google Scholar
• Van Haaften-Day C, Raghavan D, Russel P, et al. Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma. Prostate 1987; 11: 271–279
   PubMed Web of Science ®Google Scholar
• Di Sant'Agnese PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol. 1992; 23: 287–296
   PubMed Web of Science ®Google Scholar
• Chandur-Mnaymneh L, Satterfield S, Block NL. Small cell carcinoma of the prostate gland with inappropriate antidiuretic hormone secretion: morphological immunohistochemical and clinical expressions. J Urol. 1986; 135: 1263–1266
   PubMed Web of Science ®Google Scholar
• Ro JY, Tetu B, Ayala AG, et al. Small cell carcinoma of the prostate II. Immunohistochemical and electron microscopic studies of 18 cases. Cancer 1987; 59: 977–982
   PubMed Web of Science ®Google Scholar
• Azumi N, Shibuya H, Ishikura M. Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate specific antigen. Am J Surg Pathol. 1984; 8: 545–550
   PubMed Web of Science ®Google Scholar
• Ghali VS, Garcia RL. Prostatic adenocarcinoma with carcinoidal features producing adrenocorticotropic syndrome: immunohistochemical study and review of the literature. Cancer 1984; 54: 1043–1048
   PubMed Web of Science ®Google Scholar
• Fetissof F, Bruandet P, Arbeille B, et al. Calcitonin-secreting carcinomas of the prostate: an immunohistochemical and ultrastructural analysis. Am J Surg Pathol 1986; 10: 702–710
   PubMed Web of Science ®Google Scholar
• Kadmon D, Thompson TC, Lynch GR, Scardino PT. Elevated plasma chromogranin A concentrations in prostatic carcinoma. J Urol. 1991; 146: 358–361
   PubMed Web of Science ®Google Scholar
• Allsbrook WC, Simms WW. Histochemistry of the prostate. Hum Pathol. 1992; 23: 297–305
   PubMed Web of Science ®Google Scholar
• Vernon SE, Williams WD. Pre-treatment and post-treatment evaluation of prostatic adenocarcinoma for prostatic specific acid phosphatase and prostatic specific antigen by immunohistochemistry. J Urol. 1983; 130: 95–98
   PubMed Web of Science ®Google Scholar
• Cho KR, Epstein JI. Metastatic prostatic carcinoma to subdiaphragmatic lymph nodes. Am J Surg Pathol. 1987; 11: 457–463
   PubMed Web of Science ®Google Scholar
• di Sant'Agnese PA. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic and therapeutic implications. Cancer 1992; 70: 254–268
   PubMed Web of Science ®Google Scholar
• Warhol MJ, Longtine JA. The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates. J Urol. 1985; 134: 607–613
   PubMed Web of Science ®Google Scholar
• Sinha AA, Wilson MJ, Gleason DF. Immunoelectron microscopic localization of prostatic-specific-antigen in human prostate by the protein-A-gold complex. Cancer 1987; 60: 1288–1293
   PubMed Web of Science ®Google Scholar
• Mao P, Nakao K, Angrist A. Human prostatic carcinoma: an electron microscopic study. Cancer Res. 1966; 26: 955–973
   PubMed Web of Science ®Google Scholar
• Frydman CP, Bleiweiss IJ, Unger PD, Gordon RE, Brazenas WV. Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med. 1992; 116: 274–276
   PubMed Web of Science ®Google Scholar
• Weaver MG, Abdul-Karim FW, Srigley J, Bostwick DG, Ro JY, Ayala AG. Paneth cell-like change of the prostate gland. A histological immunohistochemical and electron microscopic study. Am J Surg Pathol. 1992; 16: 62–68
   PubMed Web of Science ®Google Scholar
• Weaver MG, Abdul-Karim FW, Srigley JR. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation. Am J Surg Pathol. 1992; 16: 1013–1016
   PubMed Web of Science ®Google Scholar
• di Sant'Agnese PA, de Mesy Jensen KL. Endocrine-para-crine cells of the prostate and prostatic urethra: an ultra-structural study. Hum Pathol. 1984; 15: 1034–1041
   PubMed Web of Science ®Google Scholar
• Gould VE, Memoli VA, Dardi LE. Multidirectional differentiation in human epithelial cancers. J Submicrosc Cytol. 1981; 13: 97–115
   Google Scholar
• Fuchs ME, Brawer MK, Rennels MA, Nagle RB. The relationship of basement membrane to histologic grade of human prostatic carcinoma. Mod Pathol. 1989; 2: 105–111
   PubMed Web of Science ®Google Scholar